• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    CERIS Announces Innovations in Artificial Intelligence and Machine Learning That Improve Payment Integrity

    11/14/23 7:18:00 AM ET
    $CRVL
    Specialty Insurers
    Finance
    Get the next $CRVL alert in real time by email

    FORT WORTH, Texas, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Advancements in artificial intelligence (AI) and machine learning (ML) are significantly improving results and efficiencies for payment integrity in medical claims, according to CERIS, a CorVel company.

    "CERIS leads the industry in leveraging AI and ML to automate tasks for greater efficiency and accuracy, to find patterns that may indicate fraud or systemic errors, to interpret medical language, and to summarize large amounts of information into actionable data," said Steve Sutherland, Senior Vice President of Information Systems for CERIS, a Fort Worth-based company that has pioneered the use of this technology for payment integrity.

    Sutherland notes, "Now, generative AI and machine learning are taking productivity and savings even further. For example, by efficiently using machine learning, we can more effectively identify claim combinations with high probability of upcoding, flagging them for review by the claim professionals. We can summarize medical documents, extract keywords, answer specific questions, and bring often overlooked items to the reviewer's attention. As a result, payers can more efficiently pay medical bills that are accurate and appropriate for the claim."

    Already, optical character recognition (OCR) and document extraction have increased throughput significantly. Additional benefits to CERIS clients include improved accuracy, faster turnaround time, and increased savings ratios.

    Incorporating this technology also allows review teams to spend less time on tedious manual analysis so that they can focus on higher-value, more enriching work that better serves client needs. By making their work more rewarding and meaningful, valuable employees have higher job satisfaction and are more engaged, improving employee retention. CERIS' leadership in technology elevates the efforts of professional staff and improves the outcomes delivered to clients.

    Speed and precision are essential for maintaining payment integrity in healthcare, where payers have a responsibility to promptly and accurately reimburse providers, thus avoiding time-consuming efforts to recover erroneous payments. Prepayment review is becoming the norm – making it even more important to determine if a bill is accurate in a timely manner. Utilizing these new technologies improves the process and the experience of payers and providers.

    About CERIS

    CERIS, a leader in both prospective and retrospective claims review and repricing, combines clinical expertise and cost containment solutions to ensure the accuracy and transparency in healthcare payments. Accuracy and validation services include itemization review, DRG validation, facility repricing, contract and policy applications, review of implants and devices, and primary payer cost avoidance. Its universal chargemaster contains billions of charge items from more than 97% of the nation's hospitals, helping to ensure the accuracy and objectivity of each claim review.

    Contact: Melissa Storan

    Phone: 949-851-1473

    www.corvel.com



    Primary Logo

    Get the next $CRVL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CRVL

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CRVL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    CorVel Announces Revenues and Earnings

    FORT WORTH, Texas, Feb. 03, 2026 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ:CRVL) announced the results for the quarter and year ended December 31, 2025. Revenues for the nine months ended December 31, 2025 were $710 million, a 7% increase from $664 million during the nine months ended December 31, 2024. Earnings per share for the nine months ended December 31, 2025 were $1.53, up 16% compared to $1.32 during the nine months ended December 31, 2024. Revenues for the quarter were $236 million, an increase from $228 million in the December quarter of 2024. Earnings per share for the quarter were $0.47, compared to $0.46 in the same quarter of the prior year.  Third Quarter Fiscal Year 2

    2/3/26 6:15:00 AM ET
    $CRVL
    Specialty Insurers
    Finance

    CorVel Corporation to Host Live Earnings Release Webcast

    FORT WORTH, Texas, Jan. 20, 2026 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ:CRVL), a leading provider of innovative risk management solutions, is pleased to announce that it will host a live webcast to discuss its upcoming quarterly earnings results on Tuesday, February 3, 2026, at 11:30 AM Eastern Time. The webcast will feature a discussion of CorVel's financial performance, strategic initiatives, and outlook, led by Michael Combs, President and Chief Executive Officer, alongside Brian Nichols, Chief Financial Officer. The event will also include a dedicated question-and-answer session for attendees. Webcast Details: Date: Tuesday, February 3, 2026Time: 11:30 AM ETAccess: The live

    1/20/26 8:05:00 AM ET
    $CRVL
    Specialty Insurers
    Finance

    Sarah Scott Named to Business Insurance's "Women to Watch" List for 2025

    FORT WORTH, Texas, Nov. 18, 2025 (GLOBE NEWSWIRE) -- CorVel Corporation is proud to announce that Sarah Scott, Executive Vice President of Product and Corporate Services, has been named to Business Insurance's prestigious "Women to Watch" list for 2025. Now celebrating its 20th year, the award honors women who have achieved extraordinary success in insurance and risk management through leadership, innovation, and mentorship. A 26-year veteran of CorVel, Scott has played a pivotal role in advancing the Company's product innovation, clinical integration, and digital transformation initiatives. In her current role, she oversees the development and evolution of CorVel's entire product portfol

    11/18/25 10:44:31 AM ET
    $CRVL
    Specialty Insurers
    Finance

    $CRVL
    SEC Filings

    View All

    SEC Form 10-Q filed by CorVel Corp.

    10-Q - CORVEL CORP (0000874866) (Filer)

    2/5/26 4:30:45 PM ET
    $CRVL
    Specialty Insurers
    Finance

    SEC Form S-8 filed by CorVel Corp.

    S-8 - CORVEL CORP (0000874866) (Filer)

    11/6/25 4:56:26 PM ET
    $CRVL
    Specialty Insurers
    Finance

    SEC Form 10-Q filed by CorVel Corp.

    10-Q - CORVEL CORP (0000874866) (Filer)

    11/6/25 4:30:50 PM ET
    $CRVL
    Specialty Insurers
    Finance

    $CRVL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Chief Financial Officer Nichols Brian S.

    4 - CORVEL CORP (0000874866) (Issuer)

    2/2/26 9:38:41 PM ET
    $CRVL
    Specialty Insurers
    Finance

    SEC Form 3 filed by new insider Nichols Brian S.

    3 - CORVEL CORP (0000874866) (Issuer)

    2/2/26 9:37:00 PM ET
    $CRVL
    Specialty Insurers
    Finance

    CEO & President Combs Michael G exercised 28,407 shares at a strike of $51.69 and covered exercise/tax liability with 23,959 shares, increasing direct ownership by 10% to 48,773 units (SEC Form 4)

    4 - CORVEL CORP (0000874866) (Issuer)

    1/7/26 4:28:27 PM ET
    $CRVL
    Specialty Insurers
    Finance

    $CRVL
    Leadership Updates

    Live Leadership Updates

    View All

    CorVel Corporation to Host Live Earnings Release Webcast

    FORT WORTH, Texas, Jan. 20, 2026 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ:CRVL), a leading provider of innovative risk management solutions, is pleased to announce that it will host a live webcast to discuss its upcoming quarterly earnings results on Tuesday, February 3, 2026, at 11:30 AM Eastern Time. The webcast will feature a discussion of CorVel's financial performance, strategic initiatives, and outlook, led by Michael Combs, President and Chief Executive Officer, alongside Brian Nichols, Chief Financial Officer. The event will also include a dedicated question-and-answer session for attendees. Webcast Details: Date: Tuesday, February 3, 2026Time: 11:30 AM ETAccess: The live

    1/20/26 8:05:00 AM ET
    $CRVL
    Specialty Insurers
    Finance

    CorVel Corporation to Host Live Earnings Release Webcast

    FORT WORTH, Texas, Oct. 21, 2025 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ:CRVL), a leading provider of innovative risk management solutions, is pleased to announce that it will host a live webcast to discuss its upcoming quarterly earnings results on Tuesday, November 4, 2025, at 11:30 AM Eastern Time. During the webcast, CorVel will also introduce its newly appointed Chief Financial Officer, Brian Nichols. The webcast will feature a discussion of CorVel's financial performance, strategic initiatives, and outlook, led by Michael Combs, President and Chief Executive Officer, alongside Brian Nichols. The event will also include a dedicated question-and-answer session for attendees. W

    10/21/25 9:13:00 AM ET
    $CRVL
    Specialty Insurers
    Finance

    CorVel Corporation Appoints Sarah Scott as Executive Vice President of Product

    FORT WORTH, Texas, Feb. 13, 2025 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDQ: CRVL), a national provider of risk management solutions, today announced the promotion of Sarah Scott to Executive Vice President of Product. In her expanded role, Sarah will be responsible for defining and driving the overall product vision and strategy, from ideation to launch and ongoing optimization. Sarah's leadership will ensure the company continues to deliver innovative solutions that create value and meet the evolving needs of its partners. Throughout her 25 years with CorVel, Sarah has been instrumental in the company's success. In her previous role as Vice President of Network Solutions, Sarah playe

    2/13/25 7:25:00 AM ET
    $CRVL
    Specialty Insurers
    Finance

    $CRVL
    Financials

    Live finance-specific insights

    View All

    CorVel Announces Revenues and Earnings

    FORT WORTH, Texas, Aug. 05, 2025 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ:CRVL) announced the results for the quarter ended June 30, 2025. Revenues for the quarter were $235 million, an increase from $212 million in the June quarter of 2024. Earnings per share for the quarter were $0.52, compared to $0.42 in the same quarter of the prior year.  The earnings per share numbers for the current and prior year have been adjusted to reflect the three-for-one stock split of its common stock which was paid on December 24, 2024. First Quarter Fiscal Year 2026 Highlights  Revenue increased 11% to $235 million, compared to first quarter of fiscal year 2025.Gross profit increased 18% to $5

    8/5/25 6:15:00 AM ET
    $CRVL
    Specialty Insurers
    Finance

    STAAR Surgical Announces Changes to Board of Directors

    STAAR Surgical Company (NASDAQ:STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced changes to its Board of Directors. The Company announced that the Board appointed Louis E. Silverman, who served on the Company's Board from 2014-2022, as a director, effective April 24, 2025. The Company also announced that Aimee S. Weisner, who has served as a director since 2022, has chosen not to stand for re-election to the Board when her term expires at the Company's 2025 annual meeting of shareholders in June. In addition, the Company announced that Wei Jiang, who has served as a director since 2024, has agreed to

    4/24/25 5:00:00 PM ET
    $AZN
    $CRVL
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Specialty Insurers
    Finance

    $CRVL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by CorVel Corp. (Amendment)

    SC 13G/A - CORVEL CORP (0000874866) (Subject)

    2/14/24 6:45:55 PM ET
    $CRVL
    Specialty Insurers
    Finance

    SEC Form SC 13G/A filed by CorVel Corp. (Amendment)

    SC 13G/A - CORVEL CORP (0000874866) (Subject)

    2/13/24 5:02:29 PM ET
    $CRVL
    Specialty Insurers
    Finance

    SEC Form SC 13G/A filed by CorVel Corp. (Amendment)

    SC 13G/A - CORVEL CORP (0000874866) (Subject)

    2/13/24 4:05:36 PM ET
    $CRVL
    Specialty Insurers
    Finance